Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Appointed director
CC transcript
HAEMONETICS CORP (HAE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K/A Quarterly results
10/10/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc."
08/11/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 10-Q Quarterly Report for the period ended July 1, 2023
08/08/2023 8-K Quarterly results
Docs: "Haemonetics Reports First Quarter Fiscal 2024 Results&#59; Updates Fiscal 2024 Guidance"
08/07/2023 8-K Appointed a new director
Docs: "HAEMONETICS CORPORATION AMENDED AND RESTATED 2019 LONG-TERM INCENTIVE COMPENSATION PLAN",
"Diane M. Bryant Joins Haemonetics' Board of Directors"
07/18/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 ARS Form ARS - Annual Report to Security Holders:
06/16/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/16/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/07/2023 144 Form 144 - Report of proposed sale of securities:
05/30/2023 SD Form SD - Specialized disclosure report:
05/11/2023 8-K Quarterly results
Docs: "Haemonetics Reports Fourth Quarter and Fiscal 2023 Results&#59; Provides Fiscal 2024 Guidance"
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Neuberger Berman Group LLC reports a 7.6% stake in Haemonetics Corp
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.4% stake in Haemonetics Corp.
02/07/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/07/2023 8-K Quarterly results
Docs: "Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results&#59; Updates Fiscal 2023 Guidance"
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/08/2022 10-Q Quarterly Report for the period ended October 1, 2022
11/07/2022 8-K Quarterly results
Docs: "Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results&#59; Updates Fiscal 2023 Guidance"
10/19/2022 8-K Quarterly results
10/11/2022 SC 13G/A VANGUARD GROUP INC reports a 10.1% stake in Haemonetics Corp.
08/10/2022 10-Q Quarterly Report for the period ended July 2, 2022
08/10/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
08/01/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "AMENDED AND RESTATED CREDIT AGREEMENT"
06/17/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/17/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/16/2022 8-K Quarterly results
05/26/2022 SD Form SD - Specialized disclosure report:
05/25/2022 8-K Quarterly results
05/25/2022 10-K Annual Report for the period ended April 2, 2022
05/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy